Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics?

Life Science

3 Popular U.S. High-Dividend ETFs: Income, Growth and Diversification

Consumer Goods, Financial Service, Life Science, Technology

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Life Science

AbbVie Faces a Challenger in Johnson & Johnson, but Investors Need Not Panic

Life Science

Growth Stocks Meta and Dexcom Are Suitable for Buying and Holding Long-Term

Life Science

Three AI Healthcare Stocks Chart Distinct Growth Trajectories

Life Science, Technology

Bristol-Myers Squibb’s Stock Looks Cheap on the Surface, but Hidden Risks Lurk Beneath

Life Science

Healthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio?

Life Science

This Health Insurance Company Is Approaching Its Profit Inflection Point

Life Science

5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors

Life Science

After the Market Pullback, the Defensive Value of Two Blue-Chip Stocks Stands Out

Life Science, Technology

Riding on Strong Earnings and a $1.5 Billion Market Catalyst, Exelixis Is Poised for Takeoff

Life Science

CVS Stock Soars 107%: Steady Dividends Power Its Impressive Turnaround

Life Science

Is It Wise to Follow the Herd and Buy the Same Weight-Loss Drug Giant as the U.S. President?

Life Science

Billionaires Reduce Holdings in UnitedHealth, Yet Wall Street Remains Bullish

Life Science